A citation-based method for searching scientific literature

Jaco Oosthuizen, Maritha J Kotze, Nicole Van Der Merwe, Ettienne J Myburgh, Phillip Bester, Nerina C van der Merwe. Front Oncol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer.
Sarra Henouda, Assia Bensalem, Rym Reggad, Nedda Serrar, Leila Rouabah, Pascal Pujol. Dis Markers 2016
10
50

Non-BRCA familial breast cancer: review of reported pathology and molecular findings.
Michael G Keeney, Fergus J Couch, Daniel W Visscher, Noralane M Lindor. Pathology 2017
15
50

Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients.
Hassan Jouhadi, Amal Tazzite, Houssine Azeddoug, Asmâa Naim, Sellama Nadifi, Abdellatif Benider. BMC Res Notes 2016
6
50


Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer.
Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Su-Youn Choi, Inkyung Shin, Won Park, Seung Jae Huh, Sung-Hee Han, Min Hyuk Lee, Sei Hyun Ahn,[...]. Breast Cancer Res Treat 2012
29
50

Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
S L Neuhausen, S Mazoyer, L Friedman, M Stratton, K Offit, A Caligo, G Tomlinson, L Cannon-Albright, T Bishop, D Kelsell,[...]. Am J Hum Genet 1996
229
50

Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patients.
Wala Ben Kridis-Rejeb, Dorra Ben Ayed-Guerfali, Nihel Ammous-Boukhris, Wajdi Ayadi, Chamseddine Kifagi, Slim Charfi, Ines Saguem, Tahia Sellami-Boudawara, Jamel Daoud, Afef Khanfir,[...]. Mol Biol Rep 2020
2
50

Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients.
Najah Mighri, Yosr Hamdi, Maroua Boujemaa, Houcemeddine Othman, Sonia Ben Nasr, Houda El Benna, Nesrine Mejri, Soumaya Labidi, Jihen Ayari, Olfa Jaidene,[...]. Front Genet 2020
2
50

Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.
Marcia Cruz-Correa, Julyann Pérez-Mayoral, Julie Dutil, Miguel Echenique, Rafael Mosquera, Keila Rivera-Román, Sharee Umpierre, Segundo Rodriguez-Quilichini, Maria Gonzalez-Pons, Myrta I Olivera,[...]. Hered Cancer Clin Pract 2017
14
50


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
50

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
50

Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.
Andrea Veronesi, Clelia de Giacomi, Maria D Magri, Davide Lombardi, Martina Zanetti, Cristina Scuderi, Riccardo Dolcetti, Alessandra Viel, Diana Crivellari, Ettore Bidoli,[...]. BMC Cancer 2005
58
50

BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.
Nagi S El Saghir, Nathalie K Zgheib, Hussein A Assi, Katia E Khoury, Yannick Bidet, Sara M Jaber, Raghid N Charara, Rania A Farhat, Firas Y Kreidieh, Stephanie Decousus,[...]. Oncologist 2015
32
50

On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
Nancy Hamel, Bing-Jian Feng, Lenka Foretova, Dominique Stoppa-Lyonnet, Steven A Narod, Evgeny Imyanitov, Olga Sinilnikova, Laima Tihomirova, Jan Lubinski, Jacek Gronwald,[...]. Eur J Hum Genet 2011
62
50

Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Asma Fourati, Marie-Michèle Louchez, Joelle Fournier, Amor Gamoudi, Khaled Rahal, Michèle-Véronique El May, Ahmed El May, Françoise Revillion, Jean-Philippe Peyrat. Bull Cancer 2014
19
50

BRCA mutation in high grade epithelial ovarian cancers.
Tarinee Manchana, Natacha Phoolcharoen, Patou Tantbirojn. Gynecol Oncol Rep 2019
16
50


BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Mads Thomassen, Thomas V O Hansen, Ake Borg, Henriette Theilmann Lianee, Friedrik Wikman, Inge Søkilde Pedersen, Marie Luise Bisgaard, Finn C Nielsen, Torben A Kruse, Anne-Marie Gerdes. Acta Oncol 2008
36
50

Inflammatory breast cancer in Tunisia: epidemiological and clinical trends.
Hamouda Boussen, Hatem Bouzaiene, Jamel Ben Hassouna, Tarek Dhiab, Fathi Khomsi, Farouk Benna, Amor Gamoudi, Nejib Mourali, Monia Hechiche, Khaled Rahal,[...]. Cancer 2010
39
50

Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing.
Ja-Hyun Jang, Jeong Eon Lee, Min-Jung Kwon, Chang-Seok Ki, Jong-Won Kim, Seok Jin Nam, Jung-Hyun Yang. J Hum Genet 2012
10
50

Finding the missing heritability of complex diseases.
Teri A Manolio, Francis S Collins, Nancy J Cox, David B Goldstein, Lucia A Hindorff, David J Hunter, Mark I McCarthy, Erin M Ramos, Lon R Cardon, Aravinda Chakravarti,[...]. Nature 2009
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
Sunil R Lakhani, Jorge S Reis-Filho, Laura Fulford, Frederique Penault-Llorca, Marc van der Vijver, Suzanne Parry, Timothy Bishop, Javier Benitez, Carmen Rivas, Yves-Jean Bignon,[...]. Clin Cancer Res 2005
445
50

Breast cancer in Arab populations: molecular characteristics and disease management implications.
Lotfi Chouchane, Hammouda Boussen, Konduru S R Sastry. Lancet Oncol 2013
79
50

Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?
S Lesage, S Belarbi, A Troiano, C Condroyer, N Hecham, P Pollak, E Lohman, T Benhassine, F Ysmail-Dahlouk, A Dürr,[...]. Neurology 2008
33
50

Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.
Wafa Troudi, N Uhrhammer, C Sibille, C Dahan, W Mahfoudh, C Bouchlaka Souissi, T Jalabert, L Chouchane, Y J Bignon, F Ben Ayed,[...]. J Hum Genet 2007
41
50

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.
Mary M Hulihan, Lianna Ishihara-Paul, Jennifer Kachergus, Liling Warren, Rim Amouri, Ramu Elango, Rab K Prinjha, Ruchi Upmanyu, Mounir Kefi, Mourad Zouari,[...]. Lancet Neurol 2008
113
50

The complex genetic landscape of familial breast cancer.
Lorenzo Melchor, Javier Benítez. Hum Genet 2013
76
50

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
James D Fackenthal, Olufunmilayo I Olopade. Nat Rev Cancer 2007
283
50

Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.
Muhammed Mustafa Atcı, Çağlayan Geredeli, Seval Ay, Abdullah Sakin, Biray Ertürk, Şaban Seçmeler, Serdar Arıcı, Ruhper Çekin, Nurgül Yaşar, Orçun Can,[...]. Eur J Breast Health 2021
1
100

Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.
Wijden Mahfoudh, Noureddine Bouaouina, Slim Ben Ahmed, Sallouha Gabbouj, Jingxuan Shan, Rebecca Mathew, Nancy Uhrhammer, Yves-Jean Bignon, Wafa Troudi, Amel Ben Ammar Elgaaied,[...]. Mol Biol Rep 2012
50
50

Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
Nicholas C Turner, Andrew N J Tutt. Breast Cancer Res 2012
47
50


The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.
M R Akbari, T Donenberg, J Lunn, D Curling, T Turnquest, E Krill-Jackson, S Zhang, S A Narod, J Hurley. Clin Genet 2014
43
50

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression.
Olafur A Stefansson, Jon G Jonasson, Kristrun Olafsdottir, Hordur Bjarnason, Oskar Th Johannsson, Sigridur K Bodvarsdottir, Sigridur Valgeirsdottir, Jorunn E Eyfjord. Breast Cancer Res 2011
17
50

Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences.
N Chalabi, D J Bernard-Gallon, Y J Bignon, F Kwiatkowski, M Agier, V Vidal, V Laplace-Chabaud, V Sylvain-Vidal, V Bertholet, F De Longueville,[...]. Cancer Genomics Proteomics 2008
26
50

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, Susan L Neuhausen, Stephen Fox, Beth Y Karlan, Gillian Mitchell, Paul James, Darcy L Thull, Kristin K Zorn,[...]. Breast Cancer Res 2016
43
50

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.
Supriya Behl, Nancy Hamel, Manon de Ladurantaye, Stéphanie Lepage, Réjean Lapointe, Anne-Marie Mes-Masson, William D Foulkes. Sci Rep 2020
8
50

BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.
Farid Cherbal, Rabah Bakour, Saida Adane, Kada Boualga, Gaelle Benais-Pont, Philippe Maillet. Dis Markers 2010
32
50

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R Rebbeck, Nandita Mitra, Fei Wan, Olga M Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix-Trench, Douglas F Easton, Antonis C Antoniou,[...]. JAMA 2015
252
50

BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype.
Roberta Zuntini, Laura Cortesi, Daniele Calistri, Tommaso Pippucci, Pier Luigi Martelli, Rita Casadio, Elisa Capizzi, Donatella Santini, Sara Miccoli, Veronica Medici,[...]. Oncotarget 2017
6
50

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
103
50

High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control.
Fatima-Zahra Laarabi, Ilham Ratbi, Siham Chafai Elalaoui, Loubna Mezzouar, Yassamine Doubaj, Laila Bouguenouch, Karim Ouldim, Noureddine Benjaafar, Abdelaziz Sefiani. BMC Res Notes 2017
13
50

BRCA mutation in ovarian cancer: testing, implications and treatment considerations.
Robert T Neff, Leigha Senter, Ritu Salani. Ther Adv Med Oncol 2017
44
50

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
50

The contribution of BRCA1 and BRCA2 to ovarian cancer.
Susan J Ramus, Simon A Gayther. Mol Oncol 2009
109
50

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases.
Sandrine Caputo, Louisa Benboudjema, Olga Sinilnikova, Etienne Rouleau, Christophe Béroud, Rosette Lidereau. Nucleic Acids Res 2012
62
50

Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia.
Wijden Mahfoudh, Inchirah Bettaieb, Randa Ghedira, Kaouther Snoussi, Nadia Bouzid, Zahra Klayech, Sallouha Gabbouj, Yassmine Remadi, Elham Hassen, Noureddine Bouaouina,[...]. J Transl Med 2019
8
50

BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia.
Milena Jakimovska, Ivana Maleva Kostovska, Katerina Popovska-Jankovic, Katerina Kubelka-Sabit, Mitko Karadjozov, Liljana Stojanovska, Andreja Arsovski, Snezhana Smichkoska, Emilija Lazarova, Maja Jakimovska Dimitrovska,[...]. Breast Cancer Res Treat 2018
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.